F-group (family)
611.1.1.1 TFR_dimer
Ligands and drugs
210
Member domains
100
with ligand contacts (≤ 4 Å)
47.6% of members
110
with DrugDomain annotations
52.4% of members
108
with a DrugBank compound
51.4% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 611.1.1.1 belongs to X-group 611 N-cbl like, which has 14 proteins with classified ligands. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00141 | NAG | N-Acetylglucosamine | 100 |
| DB00142 | GLU | Glutamic acid | 5 |
| DB02999 | QUS | Quisqualic acid | 3 |
| DB00128 | ASP | Aspartic acid | 1 |
| DB00134 | MET | Methionine | 1 |
| DB01592 | — | — | 1 |
| DB03434 | MPO | 3-(N-morpholino)propanesulfonic acid | 1 |
| DB03497 | OSE | L-serine O-sulfate | 1 |
| DB06928 | 24I | (2S)-2-{[HYDROXY(4-IODOBENZYL)PHOSPHORYL]METHYL}PENTANEDIOIC ACID | 1 |
| DB07754 | FBD | DCFBC | 1 |
| DB08835 | — | — | 1 |
| DB14488 | — | — | 1 |
| DB14489 | — | — | 1 |
| DB14490 | — | — | 1 |
| DB14491 | — | — | 1 |
| DB14501 | — | — | 1 |
| DB14520 | — | — | 1 |
| DB14805 | — | — | 1 |
| DB14965 | T57 | CTT-1057 | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| NAG | 2-acetamido-2-deoxy-beta-D-glucopyranose | 17 |
| SMmetal | SAMARIUM (III) ION | 8 |
| G88 | (2S)-2-(PHOSPHONOMETHYL)PENTANEDIOIC ACID | 4 |
| GLU | GLUTAMIC ACID | 4 |
| QUS | (S)-2-AMINO-3-(3,5-DIOXO-[1,2,4]OXADIAZOLIDIN-2-YL)-PROPIONIC ACID | 3 |
| BIX | (2S)-2-{[(S)-[(3S)-3-amino-3-carboxypropyl](hydroxy)phosphoryl]methyl}pentanedioic acid | 2 |
| CAmetal | CALCIUM ION | 2 |
| SDR | (2S)-2-[(N-acetyl-L-alpha-aspartyl)amino]nonanoic acid | 2 |
| 24I | (2S)-2-{[HYDROXY(4-IODOBENZYL)PHOSPHORYL]METHYL}PENTANEDIOIC ACID | 1 |
| 28Z | N-(4-{[(2-amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-gamma-glutamyl-L-glutamic acid | 1 |
| 29C | N-(4-{[(2-amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-gamma-glutamyl-L-gamma-glutamyl-L-glutamic acid | 1 |
| 29D | N-(4-{[(2-amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-gamma-glutamyl-L-gamma-glutamyl-L-gamma-glutamyl-L-glutamic acid | 1 |
| 2F7 | N-(4-fluorobenzoyl)-L-alloisoleucyl-O-[(S)-{[(1S)-1,3-dicarboxypropyl]amino}(hydroxy)phosphoryl]-L-serine | 1 |
| 2F9 | N-(4-fluorobenzoyl)-L-valyl-O-[(S)-{[(1S)-1,3-dicarboxypropyl]amino}(hydroxy)phosphoryl]-L-serine | 1 |
| 2G2 | L-gamma-glutamyl-O-[(S)-{[(1S)-1,3-dicarboxypropyl]amino}(hydroxy)phosphoryl]-L-serine | 1 |
| 2G4 | N-[(S)-hydroxy(4-phenylbutoxy)phosphoryl]-L-glutamic acid | 1 |
| 2G5 | N-[(S)-[(2S)-2-(benzoylamino)-2-carboxyethoxy](hydroxy)phosphoryl]-L-glutamic acid | 1 |
| 2GB | N-[(S)-(biphenyl-4-ylmethoxy)(hydroxy)phosphoryl]-L-glutamic acid | 1 |
| 2GR | N-[(S)-[2-(benzoylamino)ethoxy](hydroxy)phosphoryl]-L-glutamic acid | 1 |
| 2H9 | N-[(S)-[(2R)-2-(benzoylamino)-2-carboxyethoxy](hydroxy)phosphoryl]-L-glutamic acid | 1 |